شرح

The global drug discovery market is poised to grow by US$ 44.3 میلیارد از 2022 به 2028, ثبت CAGR از 8.7% در طول دوره پیش بینی, طبق StrategyHelix.

این گزارش داده های به روز اندازه بازار را برای دوره ارائه می دهد 2018-2021 و پیش بینی به 2028 covering key market aspects like sales value for drug discovery. The global drug discovery market is segmented on the basis of type, drug type, disease application, کاربر نهایی, و منطقه. بر اساس نوع, the global drug discovery market has been segmented into bioanalytical instruments, bioinformatics, cell-based assays and reagents, genomics, high-throughput screening, proteomics, دیگران. The bioanalytical instruments segment was the largest contributor to the global drug discovery market in 2021. Based upon drug type, the global drug discovery market is categorized into biologics, small-molecule drugs. On the basis of disease application, the global drug discovery market has been segmented into cancer, cardiovascular, immunological, neurological, دیگران. The cancer segment held the largest revenue share in 2021. توسط کاربر نهایی, the global drug discovery market has been segmented into academia and research institutes, contract research organizations (CROs), pharmaceutical companies. از نظر جغرافیایی, the global drug discovery market has been segmented into Asia Pacific, اروپا, آمریکای شمالی, بقیه دنیا (RoW).

The global drug discovery market is highly competitive. The competitive landscape of the industry has also been examined along with the profiles of the key players Agilent Technologies Inc., AMETEK Inc., Arrayit Corp., Becton Dickinson and Company, Biomax Informatics AG, Bio-Rad Laboratories Inc., Bruker Corp., Charles River Laboratories Inc., Danaher Corp., شرکت جنرال الکتریک (GE), Hitachi High-Technologies Corporation, Illumina Inc., JEOL Ltd., LECO Corporation, Merck KGaA, Perkin Elmer Inc., Qiagen N.V., Roche Holding AG, Shimadzu Corporation, Thermo Fisher Scientific Inc.

این گزارش منبع ارزشمندی برای شرکت ها و سازمان های فعال در این صنعت است. It provides a cohesive picture of the drug discovery market to help drive informed decision making for industry executives, سیاست گذاران, علمی, و تحلیلگران.

دامنه گزارش

تایپ کنید: bioanalytical instruments, bioinformatics, cell-based assays and reagents, genomics, high-throughput screening, proteomics, دیگران
Drug type: biologics, small-molecule drugs
Disease application: cancer, cardiovascular, immunological, neurological, دیگران
کاربر نهایی: academia and research institutes, contract research organizations (CROs), pharmaceutical companies
منطقه: آسیا و اقیانوسیه, اروپا, آمریکای شمالی, بقیه دنیا (RoW)
سال در نظر گرفته شده است: این گزارش دوره را پوشش می دهد 2018 به 2028

مزایای کلیدی برای ذینفعان

– Get a comprehensive picture of the global drug discovery market
– بخش های رشد و روند سرمایه گذاری را مشخص کنید

فهرست مطالب

قسمت 1. معرفی
– محدوده مطالعه
– دوره تحصیل
– محدوده جغرافیایی
– روش تحقیق
قسمت 2. Drug discovery market overview
قسمت 3. تفکیک بازار بر اساس نوع
– Bioanalytical instruments
– Bioinformatics
– Cell-based assays and reagents
– Genomics
– High-throughput screening
– Proteomics
– دیگران
قسمت 4. Market breakdown by drug type
– Biologics
– Small-molecule drugs
قسمت 5. Market breakdown by disease application
– Cancer
– Cardiovascular
– Immunological
– Neurological
– دیگران
قسمت 6. تفکیک بازار بر اساس کاربر نهایی
– Academia and research institutes
– Contract research organizations (CROs)
– Pharmaceutical companies
قسمت 7. تفکیک بازار بر اساس منطقه
– آسیا و اقیانوسیه
– اروپا
– آمریکای شمالی
– بقیه دنیا (RoW)
قسمت 8. شرکت های کلیدی
– Agilent Technologies Inc.
– AMETEK, شرکت.
– Arrayit Corp.
– Becton, Dickinson and Company
– Biomax Informatics AG
– Bio-Rad Laboratories, شرکت.
– Bruker Corp.
– Charles River Laboratories, شرکت.
– Danaher Corp.
– شرکت جنرال الکتریک (GE)
– Hitachi High-Technologies Corporation
– Illumina, شرکت.
– JEOL Ltd.
– LECO Corporation
– Merck KGaA
– Perkin Elmer Inc.
– Qiagen N.V.
– Roche Holding AG
– Shimadzu Corporation
– Thermo Fisher Scientific Inc.
درباره StrategyHelix
سلب مسئولیت